(Q38718049)
Statements
Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody (English)
Sylvie Jorieux
Nathalie Souyris
Ouafa Zaki
Alexandra Jacquet
Nathalie Fournier
Fabien Crozet
Christophe de Romeuf
Khalil Bouayadi
Rémi Urbain
Christian K Behrens
Philippe Mondon
Alexandre Fontayne
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference